Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Published: 17-Nov-2023 Featured companies: Piramal Pharma Solutions
Manufacturing

Having recently completed a successful rights issue related to the India stock market, Peter DeYoung, Piramal Pharma Ltd's CEO talks about the company's new and improved management programme, patient centricity and more

At this year's CPHI Barcelona, Manufacturing Chemist Stand Side caught up with Peter to discuss pharmaceutical market trends, such as the effects of the Inflation Reduction Act on the industry and reshoring, both in North America and India. 

He also provided updates on PPS’s Lexington sterile fill finish site, its integration with the Riverview API facility and the new plant's role in the company's ADCelerate programme (an integrated offering with the Grangemouth site providing rapid INDs for ADCs).

And, addressing complex lyophilised formulations, he also talked about API expansions at PPS sites worldwide and the global market demand for API/HPAPIs.
 

Manufacturing Chemist Stand Side...

'Manufacturing Chemist Stand Side' is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of 'Manufacturing Chemist Stand Side' contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

Featured companies

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life...
See more

You may also like

Manufacturing

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

Read more
US$80 million Lexington expansion to double sterile fill-finish capacity

Trending Articles

  1. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility
  2. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  3. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  4. Implementing advanced manufacturing technologies for novel therapies Michele Ghinizzini, Senior Vice President, Global Head of Engineering and Maintenance at Sanofi, explores the elements that enable the realistic implementation of advanced technologies in drug development and manufacturing
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

US$80 million Lexington expansion to double sterile fill-finish capacity
Manufacturing

Piramal Pharma Solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approximately 70-80%
Manufacturing

Piramal Pharma opens ADC manufacturing site in Grangemouth, Scotland

The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Manufacturing

Piramal reveals financial results for fourth quarter

“Over the recent years, Q4 has always been the strongest quarter for the company in terms of revenue contribution and EBITDA margin"
Manufacturing

Piramal Pharma begins production of APIs in new reactor suites

New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
Manufacturing

Piramal Pharma Solutions announces winner of its 2022 Award for Excellence in Patient Centricity

The Excellence Award recognises the hands-on application of Patient Centricity and a focus on helping to reduce the burden of disease on patients
Manufacturing

Piramal Pharma enters the stockmarket with BSE and NSE

In June 2020, Piramal had signed an agreement with The Carlyle Group to invest growth equity capital for a 20% stake in its company
Subscribe now